PROPANC BIOPHARMA, INC. (PPCB) Capital expenditures 2012–2020
PROPANC BIOPHARMA, INC. (PPCB) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2,874FY2020 · since FY2012: $3,506 → $2,874
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $2,874 | — |
| FY2017 | $9,879 | +153.2% |
| FY2016 | $3,901 | — |
| FY2015 | $0 | — |
| FY2012 | $3,506 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice